MAGEA4 and neoplasm: Mechanistic studies indicate that MAGE-A4 may contribute to chemotherapy resistance acquisition through the CDKN2A/STAT3 pathway, and is associated with the expression of PD-L1 and the apoptosis-related protein caspase-3, influencing tumor cell survival and apoptosis processes (Wan et al. 2023).